Antibiotic treatment for Shigella infections

Klontz KC, Singh N. Treatment of drug-resistant Shigella infections. Expert Rev Anti Infect Ther. 2015 Jan;13(1):69-80.

Since the introduction of sulfonamides in the late 1930s, selective pressure and the widespread dissemination of mobile genetic elements conferring antimicrobial resistance have forced clinicians to seek successive agents for the treatment of multidrug-resistant shigellosis. Over the decades, the principal antibiotics used to treat Shigella infections have included tetracycline, chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Presently, ciprofloxacin, azithromycin, and ceftriaxone serve as the mainstays of treatment, although growing evidence has documented decreased susceptibility or full resistance to these agents in some regions. With diminishing pharmaceutical options available, there is an enhanced need for preventive measures in the form of improved sanitation and hygiene standards, strict use of currently effective agents, and a safe and effective licensed vaccine.

Full-text for Emory users.

Holmes LC. Shigella. Pediatr Rev. 2014 Jun;35(6):261-2.

“The choice of which antibiotic to administer is another treatment question. A 2010 Cochrane review of 16 randomized controlled trials evaluating antibiotics for shigella dysentery found all classes of antibiotics had similar efficacy, and the authors were not able to identify a superior class of antibiotics. In the United States, the 2010 National Antimicrobial Resistance Monitoring System found 41% of Shigella species resistant to ampicillin, 48% resistant to trimethoprim-sulfamethoxazole, 2% resistant to ciprofloxacin, and less than 1% resistant to ceftriaxone. Antibiotic resistance in outbreaks has been reported to be much higher. Arvelo et al found 90% of the Shigella strains involved in a large daycare center–associated outbreak resistant to both ampicillin and trimethoprim-sulfamethoxazole. Knowing regional resistance patterns and the susceptibility pattern of the pathogen once available is essential to guide therapy.”

Full-text for Children’s and Emory users.

Christopher PR, et al. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006784.

Antibiotics reduce the duration of Shigella dysentery.Regularly updated local or regional antibiotic sensitivity patterns to different species and strains of Shigella are required to guide empiric therapy. More trials adhering to standard guidelines are required to evaluate the role of antibiotics in the treatment of severe forms of Shigella dysentery and in groups who are at high risk of complications.

Full-text for Children’s and Emory users.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s